Clinical trial
Growth Hormone Treatment Study in Children With Cystic Fibrosis
NCT00256555 · University of Texas Southwestern Medical Center, Other · Withdrawn
Key facts
| NCT number | NCT00256555 |
|---|---|
| Title | Growth Hormone Treatment Study in Children With Cystic Fibrosis |
| Official title | GROWTH HORMONE USE IN CYSTIC FIBROSIS - A MULTICENTER STUDY |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Nutropin AQ |
| Enrollment | 0 |
| Start date | Feb 1, 2000 |
| Primary completion | Dec 12, 2018 |
| Completion | Dec 12, 2018 |
| First posted | Nov 21, 2005 |
| Last update posted | Jan 10, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: